| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 352 |
| 1 | SPIRONOLACTONE | 247 |
| 2 | SACUBITRIL AND VALSARTAN | 243 |
| 3 | BISOPROLOL FUMARATE | 221 |
| 4 | APIXABAN | 152 |
| 5 | SILDENAFIL CITRATE | 138 |
| 6 | MACITENTAN | 131 |
| 7 | SILDENAFIL | 117 |
| 8 | ASPIRIN | 110 |
| 9 | EPLERENONE | 110 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ILOPROST | 14 | 0.0150 |
| 1 | EPLERENONE | 110 | 0.0084 |
| 2 | ZANUBRUTINIB | 37 | 0.0082 |
| 3 | TAFAMIDIS MEGLUMINE | 26 | 0.0054 |
| 4 | AXICABTAGENE CILOLEUCEL | 47 | 0.0046 |
| 5 | IVABRADINE | 27 | 0.0039 |
| 6 | ALDESLEUKIN | 4 | 0.0032 |
| 7 | AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE | 2 | 0.0031 |
| 8 | SILDENAFIL POWDER, | 103 | 0.0029 |
| 9 | SELEXIPAG | 73 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 400 |
| 1 | Aldosterone Antagonist [EPC] | 350 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 276 |
| 3 | Factor Xa Inhibitor [EPC] | 219 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 159 |
| 5 | Corticosteroid [EPC] | 157 |
| 6 | Endothelin Receptor Antagonist [EPC] | 151 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 151 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 146 |
| 9 | beta-Adrenergic Blocker [EPC] | 130 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 14 | 0.0150 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 47 | 0.0046 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 25 | 0.0043 |
| 3 | Lymphocyte Growth Factor [EPC] | 4 | 0.0032 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 73 | 0.0028 |
| 5 | Aldosterone Antagonist [EPC] | 350 | 0.0022 |
| 6 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 5 | 0.0022 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 26 | 0.0017 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 146 | 0.0013 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 159 | 0.0012 |